An Open-Label Study of the Safety and Efficacy of Atiprimod Treatment for Patients With Refractory or Relapsed Multiple Myeloma
Phase of Trial: Phase I/II
Latest Information Update: 21 Nov 2009
At a glance
- Drugs Atiprimod; Ursodeoxycholic acid
- Indications Multiple myeloma
- Focus Adverse reactions
- 01 Sep 2005 New trial record.